
Process Engineer, Cell Therapy Process Development
AstraZeneca
Summary
We are seeking a highly motivated Process Engineer to support late-stage cell therapy process development and characterization activities. In this role, you will play critical role in advancing late-stage cell therapy process development, process characterization, and BLA-enabling studies.
Job description
Position Summary
We are seeking a highly motivated Process Engineer to support late-stage cell therapy process development and characterization activities. In this role, you will play critical role in advancing late-stage cell therapy process development, process characterization, and BLA-enabling studies.
This position focuses specifically on cell therapy unit operations, including T-cell enrichment, activation, transduction, washes and harvest either semi-automated or fully automated equipment.
The ideal candidate brings deep technical expertise, hands-on experience with cell therapy unit operations, and demonstrates success in supporting clinical and commercial readiness.
Key Responsibilities
Process development and characterization
- Design, execute, and support autologous or allogenic cell therapy process optimization and robustness studies.
- Drive implementation of closed-system operations and automation strategies to support scalability and compliance.
- Plan and execute process characterization studies (DOE, multivariate studies, scale-down models, and scale-up assessments) in alignment with QbD and ICH guidelines.
- Perform data analysis, write technical reports, and present outcome of the studies to cross-functional teams and governance forums.
- Conduct batch record review, deviation assessment, and data trending to ensure robustness of cell therapy manufacturing processes.
- Apply AI-enabled tools and digital analytics to accelerate data review, trend analysis, batch record evaluation, and process understanding.
PPQ, Tech Transfer & Manufacturing Readiness
- Provide on-the-floor technical support during scale-up, engineering runs, PPQ batches, and commercial manufacturing campaigns (including off-shift support when required).
- Support raw material risk assessments, comparability studies, and process risk evaluations across facilities and platforms.
Cross-Functional Collaboration
- Work closely with analytical sciences and manufacturing science and technology teams to ensure end-to-end process alignment.
- Support lifecycle management, post-approval changes, and continuous improvement initiatives for cell therapy processes.
Required Qualifications
- M.S. in Chemical Engineering, Biochemical Engineering, Biotechnology, or related field with 2+ years of industry experience; OR B.S. with 7+ years of hands-on industry experience.
- Strong technical expertise in key cell therapy unit operations (e.g., cell isolation, activation, transduction, expansion, harvest, formulation, cryopreservation) or biologics.
- Demonstrated experience with GMP operations and late-stage / commercial readiness.
- Proven ability to analyze complex datasets, develop sound recommendations, and communicate clearly across levels
- Experience with late-stage development and process characterization principles for cell therapy processes.
- Demonstrated proficiency in applying AI tools and digital solutions to data analysis, documentation, and workflow automation.
- Experience working in GMP environments, including batch record execution or review, deviations, and investigations.
- Strong technical writing, data analysis, and problem-solving skills.
Preferred Qualifications
- Familiarity with automation platforms (e.g., CliniMACS Prodigy, Lovo, G-Rex, Wave bioreactors).
- Experience implementing closed, automated, or high-throughput systems.
- Experience designing and executing DOE and multivariate data analysis for cell therapy processes.
- Experience with JMP or similar statistical analysis tools.
- Formal training or demonstrated application of digitalization, automation, or AI-enabled tools in bioprocess development.
Key Competencies
- Strong experimental design and execution skills.
- Excellent cross-functional communication and collaboration.
- Ability to operate effectively in fast-paced, late-stage development environments.
- Scientific curiosity, ownership mindset, and willingness to support manufacturing operations.
Requirements
- M.S. in Chemical Engineering, Biochemical Engineering, Biotechnology, or related field with 2+ years of industry experience; OR B.S. with 7+ years of hands-on industry experience
- Strong technical expertise in key cell therapy unit operations (e.g., cell isolation, activation, transduction, expansion, harvest, formulation, cryopreservation) or biologics
- Demonstrated experience with GMP operations and late-stage / commercial readiness
- Proven ability to analyze complex datasets, develop sound recommendations, and communicate clearly across levels
- Experience with late-stage development and process characterization principles for cell therapy processes
- Demonstrated proficiency in applying AI tools and digital solutions to data analysis, documentation, and workflow automation
- Experience working in GMP environments, including batch record execution or review, deviations, and investigations
- Strong technical writing, data analysis, and problem-solving skills
- Familiarity with automation platforms (e.g., CliniMACS Prodigy, Lovo, G-Rex, Wave bioreactors)
- Experience implementing closed, automated, or high-throughput systems
- Experience designing and executing DOE and multivariate data analysis for cell therapy processes
- Experience with JMP or similar statistical analysis tools
- Formal training or demonstrated application of digitalization, automation, or AI-enabled tools in bioprocess development
Benefits
- 401(k) Retirement Programs
- Paid Time Off
- Vacation
- Holiday Pay
- Leaves
- Health Insurance
- Dental Coverage
- Vision Coverage
- Short-Term Incentive Bonuses
- Equity-Based Awards
Company overview
AstraZeneca is a global, science-led, patient-focused pharmaceutical company dedicated to accelerating the delivery of life-changing medicines that create enduring value for patients, society, and shareholders. With a workforce of over 94,300 employees worldwide, the company operates across three core therapy areas: Oncology, BioPharmaceuticals (including Cardiovascular, Renal & Metabolism, Respiratory & Immunology), and Rare Disease. Headquartered in Cambridge, UK, AstraZeneca maintains strategic R&D centers in Cambridge, Gaithersburg (US), Boston (US), Gothenburg (Sweden), Shanghai, and Beijing. The company generated $54.1 billion in total revenue in 2024 and invested $13.6 billion in scientific research and development. AstraZeneca's bold aspiration is to be pioneers in science, lead in disease areas, and transform patient outcomes, with a goal to launch 20 new medicines and achieve $80 billion in total revenue by 2030. The company is recognized for its commitment to sustainability, health equity, and creating an inclusive work environment where diverse perspectives drive innovation.